Perceptive Advisors’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Perceptive Advisors’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-52,180	Closed	-$6.2M	–	125
2019 Q3	$6.2M	Hold	52,180	–	–	0.17%	69
2019 Q2	$7.3M	Hold	52,180	–	–	0.17%	75
2019 Q1	$9.33M	Hold	52,180	–	–	0.26%	59
2018 Q4	$8.21M	Buy	+52,180	New	+$7.78M	0.31%	55

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Perceptive Advisors's ORTX Position: Q4 2019 in Review

Perceptive Advisors sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2019, closing a stake of 52,180 shares — an estimated $6.2M sold.

Perceptive Advisors first reported a position in ORTX in Q4 2018 and held it in 4 quarters. The position peaked at $9.33M in Q1 2019. 81 funds tracked by Wall St. Rank hold ORTX as of Q4 2019.

Perceptive Advisors reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
Perceptive Advisors sold 52,180 Orchard Therapeutics plc American Depositary Shares shares in Q4 2019, an estimated $6.2M.
Perceptive Advisors first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 4 quarters.
Perceptive Advisors's Orchard Therapeutics plc American Depositary Shares position peaked at $9.33M in Q1 2019.
81 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2019.

Based on Perceptive Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.